Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Waterloo

$19,500.00

Micro- and nanoscale delivery systems for macromolecules: gene delivery

EF 2009-10

Résumé
One of the biggest challenges in gene therapy -- inserting genes into an individual's cells and tissues to treat a disease -- is successfully delivering DNA into cells, followed by the DNA being expressed. In our search for suitable materials to package DNA, we have identified a group of compounds known as gemini surfactants that can condense, protect and transport DNA into cells. Using these electrically charged compounds, we have developed a non-viral nanoparticle-based technology to deliver genes through the skin. Non-viral delivery systems have significant advantages relative to viral systems, as they are safer, cheaper and easier to prepare. Their major disadvantage, however, is that they are not as efficient, a deficiency this proposed research will address. In the past three years we have made significant progress in developing gemini surfactant-based nanoparticles for gene delivery. We have used gemini nanoparticles to deliver specific genes through the skin in mice that have been bred for studies on scleroderma (a skin condition characterized by excess synthesis and deposition of collagen) and have seen a therapeutic response, which has demonstrated the feasibility of using this technology to treat genetically based skin conditions in humans. This proposed research will expand our investigation of gemini surfactants as gene delivery biomaterials. We will study the physical and chemical properties of these compounds using a variety of techniques. Based on these characterization studies, we will design novel derivatives of gemini compounds with specific characteristics for improved transport through cellular and nuclear membranes, movement within the cell and ability to target the nucleus.
Programme
Discovery Grants Program - Individual
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
155455-2008
Name nom
Foldvari, Marianna
Department département
Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2008
Award amount
19500
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
21
Committee name en
Interdisciplinary
Committee name fr
Interdisciplinaire
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
2
Nb partie
5
Application title
Micro- and nanoscale delivery systems for macromolecules: gene delivery
Keyword
NA
Application summary
One of the biggest challenges in gene therapy -- inserting genes into an individual's cells and tissues to treat a disease -- is successfully delivering DNA into cells, followed by the DNA being expressed. In our search for suitable materials to package DNA, we have identified a group of compounds known as gemini surfactants that can condense, protect and transport DNA into cells. Using these electrically charged compounds, we have developed a non-viral nanoparticle-based technology to deliver genes through the skin. Non-viral delivery systems have significant advantages relative to viral systems, as they are safer, cheaper and easier to prepare. Their major disadvantage, however, is that they are not as efficient, a deficiency this proposed research will address. In the past three years we have made significant progress in developing gemini surfactant-based nanoparticles for gene delivery. We have used gemini nanoparticles to deliver specific genes through the skin in mice that have been bred for studies on scleroderma (a skin condition characterized by excess synthesis and deposition of collagen) and have seen a therapeutic response, which has demonstrated the feasibility of using this technology to treat genetically based skin conditions in humans. This proposed research will expand our investigation of gemini surfactants as gene delivery biomaterials. We will study the physical and chemical properties of these compounds using a variety of techniques. Based on these characterization studies, we will design novel derivatives of gemini compounds with specific characteristics for improved transport through cellular and nuclear membranes, movement within the cell and ability to target the nucleus.